Evidence map›Paper›PMID 36324584›Full record

ArticleFrontiers in oncology2022

Effective prediction of potential ferroptosis critical genes in clinical colorectal cancer.

Hongliang Huang, Yuexiang Dai, Yingying Duan, Zhongwen Yuan, Yanxuan Li, Maomao Zhang, Wenting Zhu, Hang Yu, Wenfei Zhong, Senling Feng

Abstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. HMGB1: A Central Node in Cancer Therapy Resistance.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Involvement of HMGB1-mediated ferroptosis in systemic diseases.Frontiers in cell and developmental biology · 2025
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hongliang HuangDepartment of Pharmacy, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Yuexiang DaiSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, China.
Yingying DuanDepartment of Pharmacy, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Zhongwen YuanDepartment of Pharmacy, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Yanxuan LiThe Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Maomao ZhangThe Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Wenting ZhuDepartment of Pharmacy, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Hang YuDepartment of Pharmacy, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Wenfei ZhongDepartment of Pharmacy, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Senling FengDepartment of Pharmacy, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Colon cancer is common worldwide, with high morbidity and poor prognosis. Ferroptosis is a novel form of cell death driven by the accumulation of iron-dependent lipid peroxides, which differs from other programmed cell death mechanisms. Programmed cell death is a cancer hallmark, and ferroptosis is known to participate in various cancers, including colon cancer. Novel ferroptosis markers and targeted colon cancer therapies are urgently needed. To this end, we performed a preliminary exploration of ferroptosis-related genes in colon cancer to enable new treatment strategies. Methods: Ferroptosis-related genes in colon cancer were obtained by data mining and screening for differentially expressed genes (DEGs) using bioinformatics analysis tools. We normalized the data across four independent datasets and a ferroptosis-specific database. Identified genes were validated by immunohistochemical analysis of pathological and healthy clinical samples. Results: We identified DEGs in colon cancer that are involved in ferroptosis. Among these, five core genes were found: Conclusions: The preliminary exploration of the five core genes revealed that they are differentially expressed in colon cancer, playing an essential role in ferroptosis. This study provides a foundation for subsequent research on ferroptosis in colon cancer.

Indexed as

bioinformaticscolon cancerdata miningdifferentially expressed genesferroptosislipid peroxidation

Identifiers

PMID36324584
PMCPMC9619366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.